Akèy › Twoub Defisi Atansyon ak Ipèaktivite › Arkansas
Etid klinik pou Twoub Defisi Atansyon ak Ipèaktivite nan Arkansas
4 etid pou Twoub Defisi Atansyon ak Ipèaktivite ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Preferred Research Partners, Inc., Little Rock
Ap rekriteFaz 4
48 Months – 69 Months · Tout sèks · Mizajou Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Little Rock
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Little Rock
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717879The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
- University of Arkansas, Fayetteville
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou May 27, 2026 · NCT06115603Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.